2018
DOI: 10.1155/2018/8414257
|View full text |Cite
|
Sign up to set email alerts
|

Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms

Abstract: Clostridium difficile (C. difficile) is the most prevalent causative pathogen of healthcare-associated diarrhea. Notably, over the past 10 years, the number of Clostridium difficile outbreaks has increased with the rate of morbidity and mortality. The occurrence and spread of C. difficile strains that are resistant to multiple antimicrobial drugs complicate prevention as well as potential treatment options. Most C. difficile isolates are still susceptible to metronidazole and vancomycin. Incidences of C. diffi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
82
0
5

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 76 publications
(88 citation statements)
references
References 92 publications
1
82
0
5
Order By: Relevance
“…Clostridia species such as welchii and tetani respond to sulfonamides [82]. Tetracyclines, carbapenems, metronidazole, vancomycin and chloramphenicol are effective options for treatment of Clostridia infections [84].…”
Section: Clostridium Speciesmentioning
confidence: 99%
“…Clostridia species such as welchii and tetani respond to sulfonamides [82]. Tetracyclines, carbapenems, metronidazole, vancomycin and chloramphenicol are effective options for treatment of Clostridia infections [84].…”
Section: Clostridium Speciesmentioning
confidence: 99%
“…Many pathogens possess endogenous active CRISPR-Cas systems, which can be repurposed for self-targeting. Since C. difficile contains a naturally active CRISPR-Cas system, such a strategy could be promising for control and even treatment of C. difficile infection (CDI), in the context of recent worldwide emergence of antibiotic-resistant C. difficile strains ( Banawas, 2018 ). Phage therapy of CDI has proved to be another promising alternative, but it faces some difficulties including lack of appropriate phages ( Hargreaves and Clokie, 2014 ; Sekulovic et al, 2014 ).…”
Section: Potential Applications Of C Difficile Crmentioning
confidence: 99%
“…Clostridioides difficile is a medically important human enteropathogen that became a key public health concern over the last two decades in industrialized countries 1, 2 . This strictly anaerobic spore-forming Gram-positive bacterium is a major cause of antibiotic-associated nosocomial diarrhoea in adults 3 .…”
Section: Introductionmentioning
confidence: 99%